RTT106 Antibody

What is RTT106 and why is it important in chromatin research?

Rtt106 is a histone chaperone that specifically binds histone H3 acetylated at lysine 56 (H3K56ac) and facilitates nucleosome assembly during several molecular processes . It plays key roles in heterochromatin silencing, replication-dependent nucleosome assembly, and has been linked to transcriptional elongation . Rtt106's importance in chromatin research stems from its fundamental role in coordinating histone deposition and chromatin remodeling, making it an essential factor for understanding chromatin dynamics.

What structural features of RTT106 are important for its function?

Rtt106 contains a double-pleckstrin homology (PH) domain architecture with two distinct histone-binding regions . The first region is within the β-strands on the N-terminal PH domain, while the second is a nine-residue loop connecting two β-strands within the C-terminal PH domain . Crystal structure analysis has revealed that these two surface clusters are critical for Rtt106's ability to bind histones and fulfill its functions in replication and silencing . Additionally, the N-terminal region of Rtt106 mediates homo-oligomerization, which is important for its ability to bind (H3-H4)2 heterotetramers .

How does RTT106 interact with histones?

Rtt106 specifically recognizes and binds to (H3-H4)2 heterotetramers, particularly those containing H3K56ac . Through sequential affinity purification experiments, researchers have demonstrated that Rtt106 interacts with (H3-H4)2 heterotetramers both in vitro and in vivo . This binding is modulated by the acetylation of H3 lysine 56, which is catalyzed by the lysine acetyltransferase Rtt109 . Mutations in the H3K56 residue (such as H3K56R) significantly reduce the binding of H3-H4 to Rtt106, highlighting the importance of this modification .

How does RTT106 coordinate with chromatin remodeling complexes?

Rtt106 physically interacts with both the SWI/SNF and RSC chromatin remodeling complexes both in vitro and in vivo . Through GST pull-down and co-immunoprecipitation assays, researchers have demonstrated that Rtt106 is important for the recruitment of these complexes to HIR-dependent histone genes . Specifically, the Rtt106-dependent SWI/SNF recruitment to histone gene loci is cell cycle regulated and restricted to late G1 phase, just before the peak of histone gene expression in S phase . This coordination ensures proper chromatin dynamics during DNA replication and transcription.

What is the mechanism by which RTT106 oligomerization affects its function?

Rtt106 undergoes homo-oligomerization through its N-terminal domain, which is critical for its function . Mutations in this N-terminal homodimeric domain (such as V21E, L28E, I30E, and F31E) that affect formation of Rtt106 oligomers compromise the function of Rtt106 in transcriptional silencing and response to genotoxic stress . Importantly, these mutations also impair the ability of Rtt106 to bind (H3-H4)2 heterotetramers . This suggests a model where Rtt106 oligomerization creates a structural platform that enables efficient binding and deposition of histone tetramers onto DNA during chromatin assembly.

How does RTT106 contribute to maintaining genomic stability?

Rtt106 plays a crucial role in maintaining genomic stability through multiple mechanisms. First, it participates in replication-coupled nucleosome assembly, where it delivers newly synthesized H3K56ac-containing histones to replication forks . When histone binding is compromised due to mutations in the key binding surfaces, Rtt106 fails to deliver H3K56ac histones, leading to replication defects and increased sensitivity to DNA-damaging agents like camptothecin (CPT) . This sensitivity is manifested because improper nucleosome assembly during replication creates genomic instability. Additionally, Rtt106 is critical for heterochromatin silencing at regions like the HMR locus, contributing to the maintenance of genomic integrity through proper chromatin structure regulation .

What are the best approaches for studying RTT106-histone interactions?

To study Rtt106-histone interactions, several complementary approaches have proven effective:

• Co-immunoprecipitation assays: Using strains expressing tagged versions of Rtt106 (e.g., Rtt106-TAP) and histones (e.g., H3-HA), researchers can precipitate Rtt106 and analyze co-precipitating histones . This approach has been successfully used to demonstrate that Rtt106 binds (H3-H4)2 heterotetramers in vivo.

• Sequential affinity purification: This technique involves an initial purification of Rtt106-TAP using IgG beads followed by affinity purification of H3-HA using anti-HA antibody-conjugated beads . It allows researchers to distinguish between binding to histone dimers versus tetramers.

• GST pull-down assays: Using bacterially expressed GST-Rtt106 incubated with whole cell extracts from strains expressing tagged proteins of interest can reveal interaction partners .

• Site-directed mutagenesis: Creating point mutations in key residues of Rtt106 (based on structural data) allows for functional characterization of specific binding surfaces .

How can chromatin immunoprecipitation (ChIP) be optimized for RTT106 studies?

When performing ChIP assays to study Rtt106 recruitment to chromatin:

• Cross-linking conditions: Use 1% formaldehyde for 15-20 minutes at room temperature for optimal cross-linking of Rtt106 to chromatin.

• Sonication parameters: Adjust sonication conditions to obtain DNA fragments of 200-500 bp for optimal resolution.

• Antibody selection: Use highly specific antibodies against tagged versions of Rtt106 (e.g., Rtt106-TAP or Rtt106-HA) to ensure specificity and reduce background .

• Controls: Include input samples, no-antibody controls, and strains lacking the tagged protein to assess background levels and specificity.

• Cell synchronization: When studying cell cycle-dependent recruitment, synchronize cells using standard methods (e.g., α-factor arrest and release) and collect samples at defined time points to capture dynamic changes in Rtt106 recruitment .

• Quantitative PCR (qPCR): Design primers targeting specific regions of interest, such as HIR-dependent histone genes or replication origins, to quantify Rtt106 enrichment .

What methods are effective for analyzing RTT106 mutant phenotypes?

Several assays have been developed to analyze Rtt106 mutant phenotypes:

• DNA damage sensitivity assays: Spot dilutions of cells on media containing DNA-damaging agents like camptothecin (CPT) to assess replication defects . For example:

  Strain	Growth on YPD	Growth on YPD + 5μg/ml CPT
  Wild-type	++++	+++
  rtt106Δ	++++	+
  rtt106-V21E	++++	++
  rtt106-L28E	++++	+

• Silencing assays: Use reporter strains (e.g., HMR-a1Δ::URA3) to assess silencing defects through growth on 5-FOA (counter-selection for URA3 expression) or media lacking uracil .

• GFP reporter assays: Measure expression of GFP transgenes integrated at silenced loci (e.g., HMR) using flow cytometry (FACS) to quantitatively assess silencing defects in different mutants .

• Chromatin immunoprecipitation: Perform ChIP to analyze H3K56ac deposition at specific genomic loci in wild-type and mutant strains .

How should contradictory results between in vitro and in vivo RTT106 binding studies be reconciled?

When facing contradictory results between in vitro and in vivo binding studies:

• Consider physiological context: In vivo studies include the complete cellular environment with all potential cofactors and post-translational modifications, while in vitro studies may lack these elements.

• Examine experimental conditions: Differences in salt concentration, pH, or the presence of detergents can dramatically affect binding properties in vitro.

• Assess protein modifications: Check whether the Rtt106 protein or histones used in in vitro studies contain the appropriate post-translational modifications, particularly H3K56ac, which significantly enhances Rtt106 binding .

• Validate with multiple approaches: Combine different techniques (e.g., co-IP, ChIP, GST pull-down) to build a more complete picture of the interaction.

• Consider oligomerization state: Ensure that the Rtt106 protein used in in vitro studies maintains its proper oligomeric state, as mutations affecting oligomerization can compromise histone binding .

What controls are essential when analyzing RTT106 recruitment to chromatin?

When analyzing Rtt106 recruitment to chromatin, include these essential controls:

• Input controls: Always include input samples to normalize ChIP data and account for differences in starting material.

• No-antibody controls: Perform mock IPs without antibody to assess non-specific binding to beads.

• Untagged strain controls: Use strains lacking the tagged protein to determine background signal.

• Known binding site controls: Include primers for both positive control regions (known Rtt106 binding sites) and negative control regions (sites where Rtt106 is not expected to bind).

• Genetic controls: Compare wild-type strains with mutants defective in pathways that affect Rtt106 recruitment (e.g., hir1Δ, asf1Δ) to validate dependencies .

• Cell cycle controls: When studying cell cycle-dependent recruitment, confirm cell cycle stage through flow cytometry or monitoring of cell cycle markers.

How can researchers differentiate between direct and indirect effects of RTT106 mutations?

To differentiate between direct and indirect effects of Rtt106 mutations:

• Structure-guided mutations: Use the crystal structure of Rtt106 to design specific point mutations targeting distinct functional domains rather than large deletions that might disrupt multiple functions .

• Separation of function mutants: Identify mutations that affect specific functions (e.g., histone binding without affecting localization). For example, mutating residues in the histone-binding surfaces of Rtt106 impacts H3K56ac deposition without affecting the localization of Rtt106 to chromatin .

• Complementation experiments: Test whether the expression of wild-type Rtt106 in trans can rescue specific phenotypes of mutant strains.

• Protein-protein interaction assays: Systematically test whether mutations affect specific interactions (e.g., with histones, SWI/SNF, RSC) using co-IP or pull-down assays .

• Temporal analyses: Use systems like temperature-sensitive alleles or inducible degradation to study the immediate versus long-term consequences of Rtt106 dysfunction.